NASDAQ: BCRX · Drug Manufacturers - Specialty & Generic
Over the past week, Biocryst Pharmaceuticals (BCRX) logged 10 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 44% bullish but is sharply divided: News runs 100% bullish while X sits at just 0%. Wall Street is more constructive, with 10 of 11 analysts rating BCRX a buy.
There is little buzz around BCRX this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 91% buy share sits next to a crowd that ranges from X at 0% to News at 100%. No other tracker puts the two side by side.
11 analysts have weighed in: a Strong Buy consensus: 10 buy calls against 0 sell, with an average 12-month price target of $20.64.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 47 points above the crowd average of 44%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while X sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Biocryst Pharmaceuticals (BCRX) buzz held subdued around 35.8 while the price drifted down 12.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 4.9M shares. Updated Sep 26, 2026. Over the last 7 trading days, BCRX lost 1.3%. Buzz activity in the recent week averaged 34.2 and was relatively stable, swinging between 30.0 and 38.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 14 of the 15 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for BCRX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live BCRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (10 / 1 / 0) |
| Crowd bullish (7d) | 44% |
| Avg price target | $20.64 |
| Most bullish source | News, 100% |
| Most bearish source | X, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 10 |
| Market cap | $2.18B |
| P/E · Forward P/E | n/a · 14.5 |
| EPS · Beta | -$1.39 · 0.6 |
| Revenue (TTM) | $940.6M · -41% margin |
| Industry | Drug Manufacturers - Specialty & Generic |
Based on aggregated sentiment from Reddit, X and News sources, Biocryst Pharmaceuticals (BCRX) currently carries an Adanos hold signal with 65/100 conviction. The current cross-source average reads 44% bullish across 3 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Biocryst Pharmaceuticals (BCRX) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 33% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Biocryst Pharmaceuticals (BCRX), averaging 44% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and X at 0%, a 100-point spread. On the professional side, 10 of 11 analysts rate BCRX a buy.
Of the 11 analysts covering Biocryst Pharmaceuticals (BCRX), 10 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $20.64. That puts the street ahead of the crowd, which averages 44% bullish.
Biocryst Pharmaceuticals (BCRX)'s cross-source average is bearish at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 33% bullish, News reads 100% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 65/100 conviction.
The cross-source average is bearish for Biocryst Pharmaceuticals (BCRX) at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is x at 0% bullish. The hold signal carries 65/100 conviction.
News is the dominant discussion channel with 4 mentions (40% of total volume). Reddit contributes 3 mentions and X contributes 3 mentions. The cross-source average is bearish at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. BCRX's hold signal at 65/100 conviction reflects a bearish cross-source average at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The BCRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key